|
Volumn 9, Issue 23, 2002, Pages 2179-2190
|
Accelerating drug discovery by integrative implementation of laboratory automation in the work flow
a a |
Author keywords
Case studies; Combinatorial chemistry; Drug discovery; Integrative workflow concept; Laboratory automation; Parallel synthesis
|
Indexed keywords
4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE;
4 (4 FLUOROPHENYL) 2 (5 METHYL 5 MORPHOLINOCARBONYL 1,3 DIOXAN 2 YL) 5 (4 PYRIDINYL)IMIDAZOLE;
ADENOSINE A2A RECEPTOR ANTAGONIST;
ANTIRHEUMATIC AGENT;
PYRIDINE DERIVATIVE;
RPR 132331;
RPR 201227A;
RPR 203494;
RPR 238677;
TRIAZOLOPYRIDINE DERIVATIVE;
TUMOR NECROSIS FACTOR ALPHA;
UNCLASSIFIED DRUG;
ANALYTICAL EQUIPMENT;
ARTICLE;
COMBINATORIAL CHEMISTRY;
CONTROLLED STUDY;
DATA ANALYSIS;
DRUG DEVELOPMENT;
DRUG RESEARCH;
DRUG SYNTHESIS;
HUMAN;
JOB PERFORMANCE;
LABORATORY AUTOMATION;
ORGANIC CHEMISTRY;
ROBOTICS;
TECHNOLOGY;
APPARATUS, EQUIPMENT AND SUPPLIES;
AUTOMATION;
CHEMISTRY;
DRUG DESIGN;
DRUG SCREENING;
INSTRUMENTATION;
METHODOLOGY;
REVIEW;
AUTOMATION;
CHEMISTRY, PHARMACEUTICAL;
COMBINATORIAL CHEMISTRY TECHNIQUES;
DRUG DESIGN;
DRUG EVALUATION, PRECLINICAL;
EQUIPMENT AND SUPPLIES;
|
EID: 0036427644
PISSN: 09298673
EISSN: None
Source Type: Journal
DOI: 10.2174/0929867023368764 Document Type: Article |
Times cited : (23)
|
References (32)
|